Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125548383 | 12554838 | 3 | F | 1998 | 20160726 | 20160713 | 20160804 | EXP | GB-TAKEDA-2016TJP014692 | TAKEDA | 53.00 | YR | F | Y | 68.00000 | KG | 20160804 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125548383 | 12554838 | 1 | PS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 15 MG, UNK | Y | 20406 | 15 | MG | |||||||
| 125548383 | 12554838 | 2 | SS | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | UNK | Y | 20406 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125548383 | 12554838 | 1 | Dyspepsia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125548383 | 12554838 | DS |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125548383 | 12554838 | Blood magnesium decreased | |
| 125548383 | 12554838 | Chronic disease | |
| 125548383 | 12554838 | Dyspepsia | |
| 125548383 | 12554838 | Malaise | |
| 125548383 | 12554838 | Palpitations | |
| 125548383 | 12554838 | Vitamin B12 deficiency |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125548383 | 12554838 | 1 | 1997 | 20160517 | 0 |